Evobrutinib
- Generic Name
- Evobrutinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H27N5O2
- CAS Number
- 1415823-73-2
- Unique Ingredient Identifier
- ZA45457L1K
- Background
Evobrutinib is under investigation in clinical trial NCT03934502 (Effect of Meal Composition and Timing on Evobrutinib Bioavailability).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2024-04-26
- Target Recruit Count
- 267
- Registration Number
- NCT02975349
- Locations
- 🇺🇦
Research Site, Zaporizhzhia, Ukraine
🇧🇬Research Site 1, Pleven, Bulgaria
🇧🇬Research Site 2, Pleven, Bulgaria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath